Yuwei Dong

442 total citations
25 papers, 324 citations indexed

About

Yuwei Dong is a scholar working on Cancer Research, Molecular Biology and Epidemiology. According to data from OpenAlex, Yuwei Dong has authored 25 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 9 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Yuwei Dong's work include Liver Disease Diagnosis and Treatment (5 papers), Liver physiology and pathology (4 papers) and MicroRNA in disease regulation (4 papers). Yuwei Dong is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Liver physiology and pathology (4 papers) and MicroRNA in disease regulation (4 papers). Yuwei Dong collaborates with scholars based in China and United States. Yuwei Dong's co-authors include Ying Qu, Lungen Lu, Zhenghong Li, Xingpeng Wang, Kaichun Wu, Mingyi Xu, Qingqing Zhang, Binghang Li, Xiaobo Cai and Qidi Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Ethnopharmacology and Experimental Cell Research.

In The Last Decade

Yuwei Dong

23 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuwei Dong China 11 184 124 83 63 53 25 324
Hua Sun China 7 213 1.2× 213 1.7× 93 1.1× 84 1.3× 46 0.9× 10 401
Hongmei You China 13 203 1.1× 131 1.1× 95 1.1× 43 0.7× 29 0.5× 17 328
Shifeng Zhao China 5 116 0.6× 67 0.5× 87 1.0× 62 1.0× 19 0.4× 6 257
Sook In Chung South Korea 11 198 1.1× 61 0.5× 84 1.0× 111 1.8× 33 0.6× 17 377
Arturo Simoni‐Nieves Mexico 11 141 0.8× 69 0.6× 91 1.1× 47 0.7× 20 0.4× 20 293
Bénédicte Delire Belgium 8 178 1.0× 82 0.7× 149 1.8× 148 2.3× 48 0.9× 19 443
Zhibin Lin China 9 125 0.7× 59 0.5× 59 0.7× 27 0.4× 27 0.5× 16 237
Siyu Yuan China 3 202 1.1× 177 1.4× 88 1.1× 76 1.2× 226 4.3× 9 405
Yonglian Zeng China 13 196 1.1× 147 1.2× 63 0.8× 36 0.6× 24 0.5× 23 339
Yunwei Guo China 11 231 1.3× 170 1.4× 114 1.4× 64 1.0× 45 0.8× 28 462

Countries citing papers authored by Yuwei Dong

Since Specialization
Citations

This map shows the geographic impact of Yuwei Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuwei Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuwei Dong more than expected).

Fields of papers citing papers by Yuwei Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuwei Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuwei Dong. The network helps show where Yuwei Dong may publish in the future.

Co-authorship network of co-authors of Yuwei Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Yuwei Dong. A scholar is included among the top collaborators of Yuwei Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuwei Dong. Yuwei Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Jiangfeng, et al.. (2025). Predicting survival rates: the power of prognostic nomograms in distal cholangiocarcinoma. Frontiers in Oncology. 15. 1478836–1478836.
2.
Zhang, Na, et al.. (2025). Fructus arctii mitigates diabetic nephropathy via the Apoh/PPAR-γ pathway. Molecular Immunology. 181. 18–28. 1 indexed citations
3.
Lü, Zhihua, Yang Ding, Yuji Wang, et al.. (2024). Early administration of Wumei Wan inhibit myeloid-derived suppressor cells via PI3K/Akt pathway and amino acids metabolism to prevent colitis-associated colorectal cancer. Journal of Ethnopharmacology. 333. 118260–118260. 17 indexed citations
4.
5.
Li, Yang, Qianwen Ye, Zhihua Lü, et al.. (2024). Spatiotemporal heterogeneity of LMOD1 expression summarizes two modes of cell communication in colorectal cancer. Journal of Translational Medicine. 22(1). 549–549. 2 indexed citations
6.
Dong, Yuwei, Jing Zhou, Zhihua Lü, et al.. (2024). Advances in the study of antisense long‑stranded non‑coding RNAs in tumors (Review). International Journal of Oncology. 64(3). 4 indexed citations
7.
Liao, Qiong, et al.. (2023). Promotion of liver fibrosis by Y-box binding protein 1 via the attenuation of transforming growth factor-beta 3 transcription. Annals of Translational Medicine. 11(6). 259–259. 3 indexed citations
8.
Wang, Jian-Gong, Tiantian Han, Mengjuan Wang, et al.. (2023). Mutational landscape of intracranial germ cell tumors.. Journal of Clinical Oncology. 41(16_suppl). e14060–e14060. 1 indexed citations
9.
Li, Wenhua, Zhuoya Wang, Ruling Zhang, et al.. (2022). The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis. Journal of Translational Medicine. 20(1). 497–497. 26 indexed citations
10.
Zhang, Qidi, Ying Qu, Qingqing Zhang, et al.. (2022). Exosomes derived from hepatitis B virus-infected hepatocytes promote liver fibrosis via miR-222/TFRC axis. Cell Biology and Toxicology. 39(2). 467–481. 81 indexed citations
11.
Li, Chunbo, et al.. (2022). Investigating the Effect of Spherical Aluminum Particles on the Photothermal Performance of a Solar Air Collector. Sustainability. 14(21). 14107–14107. 1 indexed citations
12.
Li, Chunbo, Yuwei Dong, Xuelong Fu, Yalan Zhang, & Juan Du. (2022). Optimal Scheduling of Distributed Energy System for Home Energy Management System Based on Dynamic Coyote Search Algorithm. Sustainability. 14(22). 14732–14732. 3 indexed citations
13.
Dong, Yuwei, et al.. (2021). miR-369 inhibits Liver Cancer progression by targeting ZEB1 pathway and predicts the prognosis of HCC patients. Journal of Cancer. 12(10). 3067–3076. 12 indexed citations
14.
Feng, Yun, et al.. (2020). miR-124 regulates liver cancer stem cells expansion and sorafenib resistance. Experimental Cell Research. 394(2). 112162–112162. 27 indexed citations
15.
Wang, Yan, Yifei Wang, Rui-dan Zheng, et al.. (2018). Prediction of hepatic necroinflammatory activity in patients with chronic hepatitis B by a simple noninvasive model. Journal of Translational Medicine. 16(1). 166–166. 5 indexed citations
16.
Feng, Yun, Yuwei Dong, Junhua Xiao, et al.. (2018). MicroRNA‑449a is a potential predictor of colitis‑associated colorectal cancer progression. Oncology Reports. 40(3). 1684–1694. 17 indexed citations
17.
Qu, Ying, Lei Zong, Mingyi Xu, Yuwei Dong, & Lungen Lu. (2015). Effects of 18α-glycyrrhizin on TGF-β1/Smad signaling pathway in rats with carbon tetrachloride-induced liver fibrosis.. PubMed. 8(2). 1292–301. 22 indexed citations
18.
Dong, Yuwei. (2014). Catalase ameliorates hepatic fibrosis by inhibition of hepatic stellate cells activation. Frontiers in bioscience. 19(3). 535–535. 12 indexed citations
19.
Zong, Lei, Ying Qu, Mingyi Xu, Yuwei Dong, & Lungen Lu. (2012). 18α-Glycyrrhetinic Acid Down-Regulates Expression of Type I and III Collagen via TGF-Β1/Smad Signaling Pathway in Human and Rat Hepatic Stellate Cells. International Journal of Medical Sciences. 9(5). 370–379. 24 indexed citations
20.
Dong, Yuwei, Xingpeng Wang, & Kaichun Wu. (2009). Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor γ involves angiogenesis inhibition. World Journal of Gastroenterology. 15(4). 441–441. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hua Sun Breakdown of academic impact, for papers by Hongmei You Breakdown of academic impact, for papers by Shifeng Zhao Breakdown of academic impact, for papers by Sook In Chung Breakdown of academic impact, for papers by Arturo Simoni‐Nieves Breakdown of academic impact, for papers by Bénédicte Delire Breakdown of academic impact, for papers by Zhibin Lin Breakdown of academic impact, for papers by Siyu Yuan Breakdown of academic impact, for papers by Yonglian Zeng Breakdown of academic impact, for papers by Yunwei Guo
Rankless by CCL
2026